Around the globe, governments, institutions, healthcare professionals and investors are working on resolving rising healthcare costs, health equity, and provider shortage. This is assisted by breakthrough pharmaceutical innovation, the greater use of telehealth and automation.
Covid-19 has shown how vital the healthcare sector is. But with assets ranging from Big Pharma stocks to hospital REITs, what should investors do?
As the world grapples with current and future health crises such as the next pandemic caused by Disease X, the spotlight on healthcare is set to continue. The knock-on effects of the Covid-19 pandemic have overwhelmed healthcare systems worldwide, but there is also a greater focus on improving healthcare quality on the back of digitalisation, consumerism and the entry of non-traditional players.
